Mimdarou was established in 2009 with the aim of improving public access to pharmaceutical and natural-based supplement products. The company first entered the Iranian pharmaceutical market with the introduction of Migrayhill and Migraine-Cut, and later expanded its portfolio by launching Saliravira, continuing its path in developing herbal medicines.

Alongside scientific research and development, Mimdarou has also prioritized physical expansion. The result of this long-term vision is the large Mimdarou manufacturing facility located in the Pardis Technology Park. Today, the production lines at Mimdarou—thanks to their high capacity and advanced capabilities—not only manufacture Mimdarou’s own products but also serve as a modern, GMP-compliant site for producing a variety of pharmaceutical products developed by other pharmaceutical companies.

Mimdarou is proud to have been the production site for more than 100 pharmaceutical products, including tablets, capsules, sachets, and liquid formulations. Through these efforts, the company has contributed significantly to meeting the pharmaceutical needs of the country and has played an important role in the development of the pharmaceutical industry, particularly in eastern Tehran.